Nateglinide NDC 16571-759

NDC codes

FDA NDC Directory

Product NDC (as listed)16571-759Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16571-0759Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
16571-759-01	16571075901	100 TABLET in 1 BOTTLE (16571-759-01)Marketed from Dec 16, 2020
16571-759-09	16571075909	90 TABLET in 1 BOTTLE (16571-759-09)Marketed from Dec 16, 2020
16571-759-50	16571075950	500 TABLET in 1 BOTTLE (16571-759-50)Marketed from Dec 16, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nateglinide
Generic name (nonproprietary): nateglinide
Active ingredients: Nateglinide — 120 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Rising Pharma Holdings, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205544
Marketing start: Dec 16, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Potassium Channel Antagonists (Mechanism)
Identifiers: Product ID 16571-759_9ed1dbe4-49df-4d94-9e8b-3cdc081a3dd0SPL ID 9ed1dbe4-49df-4d94-9e8b-3cdc081a3dd0SPL set ID b41f4180-96a7-411d-b827-5021e534f556RxCUI 311919, 314142UNII 41X3PWK4O2
Pharmacologic class: Glinide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416571075901 followed by a unit qualifier and the quantity

Package 16571-0759-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 3, 2024.

Indications (excerpt from the label)

Nateglinide Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use : Nateglinide Tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Nateglinide Tablets are a glinide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use : Not for treating type 1 diabetes mellitus or diabetes ketoacidosis ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205544

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205544
Product	Strength	Form · route	Labeler	Product NDC
Nateglinide	Nateglinide 60 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-758